We are live on ! Find out more
BCM

BlueCrest Capital Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 20.01%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+20.01%
3 Year Est. Return
+41.66%
5 Year Est. Return
+41.11%
10 Year Est. Return
+377.48%
AUM
$3.75B
AUM Growth
-$109M
Cap. Flow
-$406M
Cap. Flow %
-10.83%
Top 10 Hldgs %
41.29%
Holding
1,992
New
543
Increased
357
Reduced
521
Closed
527
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGLE
1376
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$85K ﹤0.01%
2,153
+724
+51% +$27.4K
VIVE
1377
DELISTED
VIVEVE MED INC
VIVE
$84K ﹤0.01%
31
+13
+72% +$36.8K
CIG icon
1378
CEMIG Preferred Shares
CIG
$6.15B
$81K ﹤0.01%
93,038
-200,475
-68% -$194K
FSM icon
1379
Fortuna Silver Mines
FSM
$2.74B
$81K ﹤0.01%
+18,489
New +$90.7K
ASXC
1380
DELISTED
Asensus Surgical, Inc.
ASXC
$81K ﹤0.01%
1,077
-761
-41% -$51.5K
JNCE
1381
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$81K ﹤0.01%
+12,488
New +$92.9K
LEE icon
1382
Lee Enterprises
LEE
$181M
$80K ﹤0.01%
3,000
ADAM
1383
Adamas Trust
ADAM
$855M
$80K ﹤0.01%
+3,294
New +$82.4K
FIT
1384
DELISTED
Fitbit, Inc. Class A common stock
FIT
$80K ﹤0.01%
+15,000
New +$89.7K
HK
1385
DELISTED
Halcon Resources Corporation
HK
$80K ﹤0.01%
+17,896
New +$75K
CRIS icon
1386
Curis
CRIS
$9.2M
$77K ﹤0.01%
108
+8
+8% +$5.21K
GNCA
1387
DELISTED
Genocea Biosciences, Inc.
GNCA
$76K ﹤0.01%
12,241
-23,467
-66% -$124K
AVEO
1388
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$75K ﹤0.01%
+2,256
New +$58K
NVLN
1389
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$75K ﹤0.01%
25,280
-26,498
-51% -$93.8K
SCACW
1390
DELISTED
Saban Capital Acquisition Corp. Warrants
SCACW
$75K ﹤0.01%
+67,800
New +$86K
NNA
1391
DELISTED
Navios Maritime Acquisition Corporation
NNA
$74K ﹤0.01%
9,693
-13,163
-58% -$113K
HDSN
1392
Hudson Technologies
HDSN
$266M
$73K ﹤0.01%
56,820
-140,830
-71% -$250K
SIRI icon
1393
SiriusXM
SIRI
$10.4B
$73K ﹤0.01%
1,149
-13,480
-92% -$938K
STGW icon
1394
Stagwell
STGW
$2.2B
$73K ﹤0.01%
+17,583
New +$85.9K
MTNB icon
1395
Matinas BioPharma
MTNB
$1.86M
$72K ﹤0.01%
1,557
-3,388
-69% -$72.8K
WIN
1396
DELISTED
Windstream Holdings Inc
WIN
$69K ﹤0.01%
+14,086
New +$63.6K
HIMX
1397
Himax Technologies
HIMX
$2.47B
$63K ﹤0.01%
+10,655
New +$70.8K
RVLT
1398
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$63K ﹤0.01%
22,120
-16,695
-43% -$54.4K
IAG icon
1399
IAMGOLD
IAG
$8.55B
$62K ﹤0.01%
16,931
+699
+4% +$3.33K
ENPH icon
1400
Enphase Energy
ENPH
$5.52B
$61K ﹤0.01%
12,597
+1,380
+12% +$7.56K

Similar funds

BlueCrest Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, BlueCrest Capital Management held 1,992 positions worth $3.75B, down 2.8% from $3.86B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

BlueCrest Capital Management withdrew a net $406M in Q3 2018, closing 527 positions and reducing 521 holdings. Its most notable exit was State Street Real Estate Select Sector SPDR ETF, an estimated $19.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 10% a quarter earlier, followed by Financials and Industrials.

Against the trend, BlueCrest Capital Management opened a new position in Altaba Inc worth $255M.

  • BlueCrest Capital Management's largest Q3 2018 buy was Altaba Inc: 3,743,887 shares worth $255M.
  • BlueCrest Capital Management added most to State Street Financial Select Sector SPDR ETF in Q3 2018, an estimated $228M increase.
  • BlueCrest Capital Management's biggest Q3 2018 reduction was Knight Transportation, cutting an estimated $42.3M.
  • BlueCrest Capital Management fully exited State Street Real Estate Select Sector SPDR ETF in Q3 2018, selling an estimated $19.6M.
  • BlueCrest Capital Management's ten largest holdings make up 41% of its $3.75B portfolio in Q3 2018.
  • BlueCrest Capital Management opened 543 new positions and closed 527 in Q3 2018.
  • BlueCrest Capital Management's portfolio value fell 2.8% quarter-over-quarter to $3.75B.

Based on BlueCrest Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.